Two faces of BRD4: Mitotic bookmark and transcriptional lynchpin

Transcription

Volumn 4, Issue 1, 2013, Pages 13-17

  Devaiah, Ballachanda N ^a   Singer, Dinah S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Atypical kinase; BET protein; BRD4; CTD kinase; P TEFb; RNA Polymerase II

Indexed keywords

AURORA B KINASE; BROMODOMAIN 4 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOGENIN; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; RNA POLYMERASE II; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; ENZYME ACTIVITY; MITOSIS; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 84872174424     PISSN: 21541264     EISSN: 21541272     Source Type: Journal    
DOI: 10.4161/trns.22542     Document Type: Article

References (32)

1. Dey A, Ellenberg J, Farina A, Coleman AE, Maruyama T, Sciortino S, et al. A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition. Mol Cell Biol 2000; 20:6537-49; PMID:10938129; http://dx.doi.org/10.1128/MCB.20.17.6537-6549.2000.
2. Wu SY, Chiang CM. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J Biol Chem 2007; 282:13141-5; PMID:17329240; http://dx.doi.org/10.1074/jbc.R700001200.
3. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung CW, et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010; 468:1119-23; PMID:21068722; http://dx.doi.org/10.1038/nature09589.
4. Zhou M, Huang K, Jung KJ, Cho WK, Klase Z, Kashanchi F, et al. Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29. J Virol 2009; 83:1036-44; PMID:18971272; http://dx.doi.org/10.1128/JVI.01316-08.
5. Crawford NP, Alsarraj J, Lukes L, Walker RC, Officewala JS, Yang HH, et al. Bromodomain 4 activation predicts breast cancer survival. Proc Natl Acad Sci U S A 2008; 105:6380-5; PMID:18427120; http://dx.doi.org/10.1073/pnas.0710331105.
6. Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 2011; 478:524-8; PMID:21814200; http://dx.doi.org/10.1038/nature10334.
7. Mertz JA, Conery AR, Bryant BM, Sandy P, Balasubramanian S, Mele DA, et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci U S A 2011; 108:16669-74; PMID:21949397; http://dx.doi.org/10.1073/pnas.1108190108.
8. Rodriguez RM, Huidobro C, Urdinguio RG, Mangas C, Soldevilla B, Domínguez G, et al. Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer. J Mol Med (Berl) 2012; 90:587-95; PMID:22120039; http://dx.doi.org/10.1007/s00109-011-0837-0.
9. French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 2003; 63:304-7; PMID:12543779.
10. Houzelstein D, Bullock SL, Lynch DE, Grigorieva EF, Wilson VA, Beddington RS. Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4. Mol Cell Biol 2002; 22:3794-802; PMID:11997514; http://dx.doi.org/10.1128/MCB.22.11.3794-3802.2002.
11. Devaiah BN, Lewis BA, Cherman N, Hewitt MC, Albrecht BK, Robey PG, et al. BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci U S A 2012; 109:6927-32; PMID:22509028; http://dx.doi.org/10.1073/pnas.1120422109.
12. Vollmuth F, Blankenfeldt W, Geyer M. Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution. J Biol Chem 2009; 284:36547-56; PMID:19828451; http://dx.doi.org/10.1074/jbc.M109.033712.
13. Dey A, Nishiyama A, Karpova T, McNally J, Ozato K. Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol Biol Cell 2009; 20:4899-909; PMID:19812244; http://dx.doi.org/10.1091/mbc.E09-05-0380.
14. Zhao R, Nakamura T, Fu Y, Lazar Z, Spector DL. Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation. Nat Cell Biol 2011; 13:1295-304; PMID:21983563; http://dx.doi.org/10.1038/ncb2341.
15. Ottinger M, Christalla T, Nathan K, Brinkmann MM, Viejo-Borbolla A, Schulz TF. Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4-and BRD2/RING3-induced G1 cell cycle arrest. J Virol 2006; 80:10772-86; PMID:16928766; http://dx.doi.org/10.1128/JVI.00804-06.
16. Du C, Jin YQ, Qi JJ, Ji ZX, Li SY, An GS, et al. Effects of myogenin on expression of late muscle genes through MyoD-dependent chromatin remodeling ability of myogenin. Mol Cells 2012; 34:133-42; PMID:22814845; http://dx.doi.org/10.1007/s10059-012-2286-1.
17. Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan WI, et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 2011; 478:529-33; PMID:21964340; http://dx.doi.org/10.1038/nature10509.
18. Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell 2005; 19:523-34; PMID:16109376; http://dx.doi.org/10.1016/j.molcel.2005.06.027.
19. Rahman S, Sowa ME, Ottinger M, Smith JA, Shi Y, Harper JW, et al. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol 2011; 31:2641-52; PMID:21555454; http://dx.doi.org/10.1128/MCB.01341-10.
20. Yang Z, He N, Zhou Q. Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression. Mol Cell Biol 2008; 28:967-76; PMID:18039861; http://dx.doi.org/10.1128/MCB.01020-07.
21. You J, Li Q, Wu C, Kim J, Ottinger M, Howley PM. Regulation of aurora B expression by the bromodomain protein Brd4. Mol Cell Biol 2009; 29:5094-103; PMID:19596781; http://dx.doi.org/10.1128/MCB.00299-09.
22. Nishiyama A, Dey A, Tamura T, Ko M, Ozato K. Activation of JNK triggers release of Brd4 from mitotic chromosomes and mediates protection from drug-induced mitotic stress. PLoS One 2012; 7:e34719; PMID:22567088; http://dx.doi.org/10.1371/journal.pone.0034719.
23. Ai N, Hu X, Ding F, Yu B, Wang H, Lu X, et al. Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation. Nucleic Acids Res 2011; 39:9592-604; PMID:21890894; http://dx.doi.org/10.1093/nar/gkr698.
24. Bartkowiak B, Mackellar AL, Greenleaf AL. Updating the CTD Story: From Tail to Epic. Genet Res Int 2011; 2011:623718; PMID:22567360; http://dx.doi.org/10.4061/2011/623718.
25. Egloff S, Dienstbier M, Murphy S. Updating the RNA polymerase CTD code: adding gene-specific layers. Trends Genet 2012; 28:333-41; PMID:22622228; http://dx.doi.org/10.1016/j.tig.2012.03.007.
26. Gegonne A, Weissman JD, Lu H, Zhou M, Dasgupta A, Ribble R, et al. TFIID component TAF7 functionally interacts with both TFIIH and P-TEFb. Proc Natl Acad Sci U S A 2008; 105:5367-72; PMID:18391197; http://dx.doi.org/10.1073/pnas.0801637105.
27. Price DH. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol 2000; 20:2629-34; PMID:10733565; http://dx.doi.org/10.1128/MCB.20.8.2629-2634.2000.
28. Czudnochowski N, Bosken CA, Geyer M. Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition. Nature Communications 2012; DOI:10.1038/ncomms1846.
29. Devaiah BN, Singer DS. Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation. J Biol Chem 2012; PMID:23027873; http://dx.doi.org/10.1074/jbc.M112.412015.
30. Wang R, Li Q, Helfer CM, Jiao J, You J. Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure. J Biol Chem 2012; 287:10738-52; PMID:22334664; http://dx.doi.org/10.1074/jbc.M111.323493.
31. Akoulitchev S, Chuikov S, Reinberg D. TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 2000; 407:102-6; PMID:10993082; http://dx.doi.org/10.1038/35024111.
32. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, et al. Selective inhibition of BET bromodomains. Nature 2010; 468:1067-73; PMID:20871596; http://dx.doi.org/10.1038/nature09504.